Category: Pharmaceuticals
Pharmaceuticals market research reports by Plunkett Research, Ltd.
-
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save co ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325411
Revenue Forecasts to (2031) and Analytics for the Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325411 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325400
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325400 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save count ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000
Revenue Forecasts to (2031) and Analytics for the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and fore ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424210
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424210 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless ho ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424200
Revenue Forecasts to (2031) and Analytics for the Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424200 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save coun ... Read More
-
Financial Analysis and Multi-Year Benchmarking: ARS Pharmaceuticals Inc (SPRY:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: ARS Pharmaceuticals Inc (SPRY:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: ARS Pharmaceuticals Inc (SPRY:NAS). Includes Industry Aver ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Vertex Inc (VERX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Vertex Inc (VERX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Vertex Inc (VERX:NAS). Includes Industry Averages & Top Competitors, KP ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Phathom Pharmaceuticals Inc (PHAT:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Phathom Pharmaceuticals Inc (PHAT:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Phathom Pharmaceuticals Inc (PHAT:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Xeris Pharmaceuticals Inc (XERS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Xeris Pharmaceuticals Inc (XERS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Xeris Pharmaceuticals Inc (XERS:NAS). Includes Industry ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Recursion Pharmaceuticals Inc (RXRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Recursion Pharmaceuticals Inc (RXRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Recursion Pharmaceuticals Inc (RXRX:NAS). Includes I ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Lipella Pharmaceuticals Inc (LIPO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Lipella Pharmaceuticals Inc (LIPO:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Lipella Pharmaceuticals Inc (LIPO:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Organon and Co (OGN:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Organon and Co (OGN:NYS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Organon and Co (OGN:NYS). Includes Industry Averages & Top Competito ... Read More
-
Financial Analysis and Multi-Year Benchmarking: 60 Degrees Pharmaceuticals Inc (SXTP:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: 60 Degrees Pharmaceuticals Inc (SXTP:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: 60 Degrees Pharmaceuticals Inc (SXTP:NAS). Includes ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Zevra Therapeutics Inc (ZVRA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Zevra Therapeutics Inc (ZVRA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Zevra Therapeutics Inc (ZVRA:NAS). Includes Industry Averag ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Tarsus Pharmaceuticals Inc (TARS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Tarsus Pharmaceuticals Inc (TARS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Tarsus Pharmaceuticals Inc (TARS:NAS). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Verrica Pharmaceuticals Inc (VRCA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Verrica Pharmaceuticals Inc (VRCA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Verrica Pharmaceuticals Inc (VRCA:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Amylyx Pharmaceuticals Inc (AMLX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Amylyx Pharmaceuticals Inc (AMLX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Amylyx Pharmaceuticals Inc (AMLX:NAS). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Kineta Inc (KA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Kineta Inc (KA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Kineta Inc (KA:NAS). Includes Industry Averages & Top Competitors, KPIs, ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Petros Pharmaceuticals Inc (PTPI:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Petros Pharmaceuticals Inc (PTPI:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Petros Pharmaceuticals Inc (PTPI:NAS). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Mirum Pharmaceuticals Inc (MIRM:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Mirum Pharmaceuticals Inc (MIRM:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Mirum Pharmaceuticals Inc (MIRM:NAS). Includes Industry ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Aclaris Therapeutics Inc (ACRS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Aclaris Therapeutics Inc (ACRS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Aclaris Therapeutics Inc (ACRS:NAS). Includes Industry Av ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Eagle Pharmaceuticals Inc (EGRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Eagle Pharmaceuticals Inc (EGRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Eagle Pharmaceuticals Inc (EGRX:NAS). Includes Industry ... Read More
-
Financial Analysis and Multi-Year Benchmarking: RVL Pharmaceuticals PLC (RVLPQ:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: RVL Pharmaceuticals PLC (RVLPQ:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: RVL Pharmaceuticals PLC (RVLPQ:PINX). Includes Industry ... Read More
Research Assistance
